MoneyWorks4Me

Gufic Biosciences informs about press release

05 Apr 2022 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gufic Biosciences has informed that it enclosed a press release being issued by the Company titled ‘Gufic receives DCGI nod for Thymosin Alpha – 1’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..